basic research

Alan I. Leshner, PhD In a recent op-ed published in the Toronto Star Dr. Alan Leshner, Research!America board member, writes that federal deficits in the United States and Canada ’€œpose a significant threat’€ to basic research. He notes that ’€œsome policy-makers seem to value near-term, industry-focused science more highly.’€ But adds that basic science has larger potential payoffs than applied research. ’€œThe most well-known example of life-changing basic research is of course Sir Alexander Fleming ’€™s accidental 1928 discovery of a mould (penicillin) that seemed to repel bacteria. German physicist Wilhelm Röntgen ’€™s 19th century efforts to pass cathode rays through glass now...
On December 3, Policy Cures released its fifth annual G-FINDER report , a comprehensive survey of funding for research and development for neglected diseases. The report tracks global public, private and philanthropic investments into R&D for 31 diseases, including HIV/AIDS, tuberculosis, malaria and NTDs. In positive news, this year’€™s report shows that total funding has actually increased by $443 million since 2007. The report demonstrates that government funding, which accounts for over two-thirds of all investment, is increasingly going toward basic academic research, rather than product development. Research!America believes it is vital that the entire research pipeline be fully...


Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco